Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix vs Goserelin for Prostate Volume Reduction in Prostate Cancer
NCT00884273Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Aug 2009
- Primary completion
- Mar 2011
- Modality
- Peptides, Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Aug 2009; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00884273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00884273.